A security guard in the dusty Nigerian city of Kano is living with tragedy -- a 14-year-old son whose dazed eyes, uneven gait and slow speech signal brain damage.
Mustapha Mohammed says he knows who to blame -- Pfizer Inc, the world's largest drug maker.
New York-based Pfizer is facing four court cases -- two filed by the federal government, two by the state in recent months -- in Nigeria over a decade-old drug trial that included Mohammed's son.
The company, which denies any wrongdoing, is accused of using a 1996 meningitis epidemic to push through a sloppily managed study without the full understanding of parents or proper regulatory approval, contributing to death in some and infirmities in others.
Whether Pfizer acted improperly, the fallout provides a case study of the ethical dilemmas that arise when Western medical priorities run into Third World poverty and ignorance. The communication gap between those handing out medical alms and those receiving has bred mistrust and anger in Kano -- with damaging, far-reaching effect.
In 2003, residents of Kano and the state of the same name boycotted a polio vaccine effort on charges that it was a Western plot to make Africans infertile. The Pfizer uproar has been cited as one reason for suspicion about Western medicine.
Without mass vaccination, polio exploded in Nigeria and eventually spread to 25 previously polio-free countries.
Though the meningitis epidemic is long over and the polio vaccination program is back on track, suspicions persist.
permission
Mohammed is sure no one asked his permission to test a drug on his child. But he also wasn't asking many questions when he rushed his son to the hospital in 1996.
"We were desperate for drugs. We just took it in good faith," said Mohammed, who lives in a tiny house off a dirt road in one of Kano's poorer neighborhoods. Mohammed -- who can't read or write -- only later found out that the pink paper he kept with Pfizer's name and treatment dates meant his son had been in the study.
Pfizer says it explained the study to families using practices in line with US and international guidelines, even employing local, Hausa-speaking doctors and nurses. Written permission was obtained when possible, or oral consent if they were illiterate.
Across town, Abu Abdullahi Madaki can't be sure if her daughter Firdausi took part in the Pfizer study. Citing privacy concerns, Pfizer has declined to release the names of the 200 children it treated.
All Madaki knows is she took a feverish 8-month-old infant to the hospital in 1996, and now her daughter suffers severe brain damage that left her unable to sit up or talk.
Meningitis -- a brain infection -- leaves 10 percent to 20 percent of survivors with mental damage, hearing loss or learning disabilities, according to the WHO.
But Madaki said: "My younger sister had meningitis, but it was nothing like this. My younger sister is now a mother with children."
Madaki, who is illiterate, said she'd always felt that the hospital did something wrong, and decided when she heard about the charges against Pfizer on the radio that her daughter must have been in the study.
Pfizer says it brought the drug -- an antibiotic called Trovan -- to Nigeria as a humanitarian effort. Trovan had already gone through human trials in the US. It was a tablet, which could be easier to use with children than the standard meningitis treatment -- a painful injection.
"When this epidemic occurred, the government asked people to come and help them," said Ngozi Edozien, regional director of the Pfizer branch that covers Nigeria. She said Pfizer wanted to help, but could only offer Trovan through a clinical trial because the drug was not yet approved.
pulled
Trovan was approved in the US in 1997, but later pulled from the market in favor of other similar drugs because it was shown to cause serious liver damage.
The Kano trial showed a similar survival rate for the 100 children on Trovan with the 100 on the standard treatment. Five of the children on Trovan died, compared with six in the control group -- rates comparable to those of Western hospitals, according to Pfizer.
More than 11,000 children died in Nigeria during the epidemic.
It's hard to know if truly "informed consent" is possible during a health care crisis among a widely uneducated, isolated population.
"If you're sick and trying to get health care and somebody says to you, `Do you want to be in a research study?' If somebody is not familiar with the idea of a research study, it becomes more difficult for them to evaluate," said Benjamin Wilfond, head of Seattle's Treuman Katz Center For Pediatric Bioethics.
But if the people of Kano were uninformed, it's not just a US drug company that's to blame. Lawyers for the study families say the government failed to guard its citizens.
Ali Ahmad, who brought a class action suit on behalf of Kano subjects against Pfizer in the US, said he also wanted to sue the Nigerian government, but no government workers would testify.
The US suit was turned down for lack of jurisdiction, though Ahmad plans to appeal.
He argues that the Nigerian government is now taking advantage of the families' plight to enrich itself. A victory in the Nigerian cases will go not to families but to government coffers in a country that watchdog groups routinely call one of the most corrupt in the world.
Government lawyers say they were slow to file charges because the details of the 1996 trial have been hard to get from Pfizer. They claim that the administration was duped along with the study subjects.
"What the government did was to give Pfizer the benefit of the doubt, and obviously naively trusted Pfizer," said government prosecutor Babatunde Irukera.
‘ABUSE OF POWER’: Lee Chun-yi allegedly used a Control Yuan vehicle to transport his dog to a pet grooming salon and take his wife to restaurants, media reports said Control Yuan Secretary-General Lee Chun-yi (李俊俋) resigned on Sunday night, admitting that he had misused a government vehicle, as reported by the media. Control Yuan Vice President Lee Hung-chun (李鴻鈞) yesterday apologized to the public over the issue. The watchdog body would follow up on similar accusations made by the Chinese Nationalist Party (KMT) and would investigate the alleged misuse of government vehicles by three other Control Yuan members: Su Li-chiung (蘇麗瓊), Lin Yu-jung (林郁容) and Wang Jung-chang (王榮璋), Lee Hung-chun said. Lee Chun-yi in a statement apologized for using a Control Yuan vehicle to transport his dog to a
EUROPEAN TARGETS: The planned Munich center would support TSMC’s European customers to design high-performance, energy-efficient chips, an executive said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday said that it plans to launch a new research-and-development (R&D) center in Munich, Germany, next quarter to assist customers with chip design. TSMC Europe president Paul de Bot made the announcement during a technology symposium in Amsterdam on Tuesday, the chipmaker said. The new Munich center would be the firm’s first chip designing center in Europe, it said. The chipmaker has set up a major R&D center at its base of operations in Hsinchu and plans to create a new one in the US to provide services for major US customers,
BEIJING’S ‘PAWN’: ‘We, as Chinese, should never forget our roots, history, culture,’ Want Want Holdings general manager Tsai Wang-ting said at a summit in China The Mainland Affairs Council (MAC) yesterday condemned Want Want China Times Media Group (旺旺中時媒體集團) for making comments at the Cross-Strait Chinese Culture Summit that it said have damaged Taiwan’s sovereignty, adding that it would investigate if the group had colluded with China in the matter and contravened cross-strait regulations. The council issued a statement after Want Want Holdings (旺旺集團有限公司) general manager Tsai Wang-ting (蔡旺庭), the third son of the group’s founder, Tsai Eng-meng (蔡衍明), said at the summit last week that the group originated in “Chinese Taiwan,” and has developed and prospered in “the motherland.” “We, as Chinese, should never
‘A SURVIVAL QUESTION’: US officials have been urging the opposition KMT and TPP not to block defense spending, especially the special defense budget, an official said The US plans to ramp up weapons sales to Taiwan to a level exceeding US President Donald Trump’s first term as part of an effort to deter China as it intensifies military pressure on the nation, two US officials said on condition of anonymity. If US arms sales do accelerate, it could ease worries about the extent of Trump’s commitment to Taiwan. It would also add new friction to the tense US-China relationship. The officials said they expect US approvals for weapons sales to Taiwan over the next four years to surpass those in Trump’s first term, with one of them saying
RSS